索坦(舒尼替尼)是一种口服抗癌药物。

SUTENT is an anticancer drug that you take by mouth.

youdao

辉瑞对舒尼替尼的乳腺癌研究已进入后期。

Pfizer is in the final stage of study generally required for u.

youdao

使用索坦(舒尼替尼)有哪些严重的副作用？

What serious side effects might I have while taking SUTENT?

youdao

索坦(舒尼替尼)会与其他药发生相互作用吗？

Will SUTENT react with any other drugs I'm taking or products I'm using?

youdao

在这些患者中舒尼替尼和卡培他滨的剂量逐步递增。

Sunitinib and capecitabine doses were escalated in serial patient cohorts.

youdao

目的评价单中心舒尼替尼治疗转移性肾脏透明细胞癌的疗效和安全性。

Objective To evaluate the efficacy and safety of sunitinib in the treatment of metastatic renal clear cell carcinoma in our single center.

youdao

结论苹果酸舒尼替尼可呈浓度和时间依赖地抑制膀胱癌t 24细胞系增殖。

Conclusion Sunitinib inhibited bladder cell line T24 proliferation in dose-dependent and time dependent manner.

youdao

结论：苹果酸舒尼替尼可呈浓度和时间依赖地抑制膀胱癌t 24细胞系增殖。

Conclusions: Sunitinib inhibited bladder cell line T24 proliferation in dose-dependent and time dependent manner.

youdao

在研究的所有亚组中，根据基线特征进行的PFS的Cox风险比例分析均有利于舒尼替尼。

Cox proportional-hazards analysis of progression-free survival according to baseline characteristics favored sunitinib in all subgroups studied.

youdao

在研究的所有亚组中，根据基线特征进行的PFS的Cox风险比例分析均有利于舒尼替尼。

Cox proportional-hazards analysis of progression-free survival according to baseline characteristics favored sunitinib in all subgroups studied.

youdao